1. BENEFITS OF OBESITY
"…It may happen that you dislike a thing which is good for you,
and it may be that you love a thing which is bad for you.
Allah knows, while you know not." Qur'an [Surah Baqara 2:216]
In America an obese (a fatty) person, in some cases is frowned upon. Majority of
Americans dislike the human fat, which is scorned and despised and ruthlessly
vacuumed from bellies and backsides by suction-assisted lipectomy (i.e., liposuction)
may have a redeeming feature after all. This much-accused tissue appears to be a rich
source of stem cells, prized by scientists for their seemingly magical power to turn
into a variety of tissue types. These tissues can be replacements for almost any part of
the human body without the problems of rejection. Rejection is a colossal problem
currently in human organ transplants.
What are Stem Cells?
Stem cells are living cells that can develop into many different types of tissue, such as
bone, muscle or brain. There are three basic types: (1) "Totipotent" stem cells These
cells are formed when a fertilized egg first divides- can turn into any type of tissue
and form a "total" organism. After five days after fertilization, a hollow ball of about
100 cells called a blastocyst forms. The cells on the outside develop into the placenta,
while those on the inside turn into the embryo itself. (2) The 50 or so inner cells are
"pluripotent" - they can turn into almost all types of tissue, but not a whole organism.
As the embryo develops further, stem cells become (3) "multipotent" - they can give
rise only to specific kinds of cells. Totipotent and pluripotent cells are also known as
adult stem cells.
What kind is useful?
If they had their way most physicians would go for pluripotent stem cells because
these can give all the types of tissues one needs, but cannot turn into a whole human
being.
From where to get them?
At present the only place to get them is from human embryos, which is the one reason
why pro-life groups are so opposed to stem cell research. Three research groups
around the world have found ways to grow potentially limitless supplies of
pluripotent cells in the lab - but these did come from embryos in the first place. If a
patient were given organs grown from somebody else's cells, the patient has to take
immunosuppressant drugs for the rest of his or her life.

2. Obtaining stem cells-primitive cells with the potential to become virtually any type of
tissue-from adipose tissue or fat collected by liposuction - a cosmetic procedure - and
converted them into becoming muscle, bone or cartilage, depending on the conditions
in which they were grown, scientists, reported in the journal Tissue Engineering
(Volume 7, Number 2: 211-218, April 2001). This article titled "Multilineage cells
from human adipose tissue: implications for cell-based therapies, was authored by
Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP,
Hedrick MH of the Laboratory for Regenerative Bioengineering and Repair,
Department of Surgery and Orthopaedic Surgery, UCLA School of Medicine, Los
Angeles, California. Tissue Engineering is the application of the principles of life
sciences and engineering to develop biological substitutes for the restoration or
replacement of tissue or organ function.
Stem Cells are undifferentiated cells in an embryo or adult which can undergo
unlimited division and give rise to one or several different cell types. In adults an
undifferentiated cell from which some renewable tissues (blood, skin, etc. ) are
formed.
Human adipose tissue (fat) obtained by suction-assisted lipectomy (i.e. liposuction)
was processed to obtain a fibroblast-like population of cells or a processed
lipoaspirate (PLA). These PLA cells can be maintained in vitro (outside the body) for
extended periods with stable population doubling and low levels of senescence.
Immunofluorescence and flow cytometry show that the majority of PLA cells are
mesodermal or mesenchymal origin with low levels of contaminating pericytes,
endothelial cells, and smooth muscle cells. Finally, PLA cells differentiate in vitro
into adipogenic (fat), chondrogenic (cartilage), myogenic (muscle), and osteogenic
(bone) cells in the presence of lineage-specific induction factors. This pioneering
study concludes that the data support the hypothesis that a human lipoaspirate
contains multipotent cells and may represent an alternative stem cells source to bone
marrow-derived MSCs (mesenchymal stem cells).
The discovery means that a person's own fat might one day be used to provide the
tissue needed to treat disease or repair injured or worn-out parts. From cartilage
implants in damaged knees to brain implants for Parkinson's disease and strokes.
Theoretically, people might be able to get rid of their love handles while supplying
the material needed to fix a creaky knee or hip. Unlike a transplant, tissue created by a
person's owns stem cells would pose no risk of rejection or exposure to viruses from a
donor.
"Fat may be a practical source of cells from which to make new tissues," said Dr.
Marc H. Hedrick, the lead author and an assistant professor of surgery and pediatrics
at the university of California at Los Angeles and the director of the study, in which
researchers from the University of Pittsburgh collaborated. "We don't yet know the
limits for stem cells found in fat," said Dr. Adam J. Katz of the University of
Pittsburgh, a co-author. " So far, we have seen promising results with all of the tissue
types we have examined." The Bush administration is contemplating to ban the use of
embryonic stem cells from aborted tissues, and hence this new discovery offers an
alternative source that could be much more abundant and much less contentious.
"This could take the air right out of the debate about embryonic stem cells," said Dr.
Hedrick. The newly identified cells have so many different potential applications, he

3. added, that "it makes it hard to argue that we should use embryonic cells." "This
changes the way we think about fat tissue," Dr. Hedrick said. "It's not a static spare
tire around our waist. It 's really a dynamic tissue, and there are a lot of things in it
that could help us fix people with diseases." (NY Times April 10, 2001).
"This is extremely significant in terms of its potential," said Dr. Michael T. Longaker
of Stanford University. "Unfortunately, fat is a substantial natural resource in the
USA. This is a great way to do something with it." (The Courier-Journal, Louisville,
KY April 10, 2001)
During the 1990s, researchers have found that adults also have stem cells in a variety
of locations, ranging from bone marrow, to the brain. Since they are present in small
numbers and recovering them could be difficult and painful. Small amounts of stem
cells can be extracted from bone marrow, but removing marrow from a patient can be
painful. For example to extract stem cells from the bone marrow requires drilling a
tiny hole directly in the bone, which remains painful for weeks after the procedure.
Furthermore the yield is small, usually about a few milliliters (ml). Stem cells for
research has been collected from bone marrow, brain or fetal tissue. But the use of
fetal tissue has provoked ethics disputes, and performing brain surgery to harvest stem
cells is not practical.
On the other hand Liposuction is much easier to perform through an incision in the
skin that about one inch long and is relatively painless. And liters of fat is harvested
and tossed away-producing a thousand times as many stem cells as can be obtained
from bone marrow. In older adults, the percentage of stem cells is even higher in fat
cells than in bone marrow. Since each person serves as his or own fat donor, there
would be no problem with rejection of implanted cells. Researchers looked for stem
cells in fat because fat, marrow and bone in humans developed from the same layer of
embryonic tissue, the mesoderm, and tissues from the same origin often had
properties in common. So if bone marrow has stem cells, then it is logical to think that
fat should have them too. The researchers saved fat from liposuction and processed it
to isolate cells thought to include stem cells. To get things revved up, the cells have to
be fed with the right stuff.
To coax the cells to make bone, for instance, the researchers used a medium
containing calcium, phosphate and vitamin C. They varied the conditions to grow
cartilage, muscle or more fat cells. Stem cells can be converted into specific tissues by
exposing them to complex mixture of growth hormones and other chemicals, which
requires a different formula for each desired tissue. The bottom line is finding what
needs to be included in each formulation.
The study was the first to find stem cells in fat and use them to grow different tissues.
Like any other study, other researchers to find out whether the conclusions hold up
must repeat it. Another team at Duke University has produced similar results, turning
stem cells from fat into cartilage. "It's very important for different groups to reach the
same conclusion with a study with this much potential impact," said Dr. Farshid
Guilak, leader of the Duke study. Both the Stanford and Duke groups are executing
tissue examinations in animals, and both suggested that for the first clinical trials to be

4. conducted in humans, it may take up to five years. Repairing of knees and other
joints, as well as noses and ears by cartilage implants will be the initial utilization of
this discovery. Laboratory grown Cartilage cells are being used in the reconstruction
of damaged knees, but the use of stem cells would astoundingly increase the supply of
tissue available. The organs and tissues that resist healing such as broken and
impaired bones could be repaired. This item is also high on the agenda. The stem cells
might be used for a much extensive diversity of applications, including brain implants
for Parkinson's disease and strokes (brain attacks), and in the repair of heart tissues,
are all possibilities in the future. Now, embryonic stem cells that secrete vital
hormones are used to treat victims of Parkinson's and Huntington's diseases, for
example.
In the adult human body most of the cells are somatic cells. These somatic cells are
called differentiated cells and have adopted an indelible identity- skin, heart, muscle,
whatever the case and they cannot be changed. Skin cells, for example, cannot be
converted into bone, cartilage or brain tissue, or vice versa. But embryos have a large
percentage of genetically unprogrammed or undifferentiated cells that have the
potential to become any kind of cell in the body. All other cells stem from these
undifferentiated cells, hence the name stem cells them. The stem cells are a premium
for researchers and clinicians, but their use is highly disputed because the only way to
obtain them is through a miscarriage.
Even if they do, using fat to provide tissue for patients is a long way off and a
procedure for doing so is not clear. Scientists must determine, for instance, whether
stem cells can be given to patients or whether the cells must be cultured in the
laboratory to turn them into the desired tissue, then implanted where needed. Actual
tests involving humans are likely five years away.
Eight years ago, President Clinton reversed a ban on federal funding for research on
embryonic stem cells, but many observers believe that Bush administration officials
will restore the ban. Performing research on fetuses obtained from abortion or
miscarriages has become a political hotchpotch. Hence the scientific research
community is taking the wrath of the anti-abortion groups. In the eighties President
Ronald Reagan prohibited federal funding of research that utilized fetal tissue. They
were transplanting more matured cells to treat Parkinson's disease and in the pancreas
of diabetics. Our President Bush's father supported this ban when he was President
(1988-1992). When Bill Clinton became the President he reversed the ban of his
Republican predecessors. President Clinton's federally funded fetal tissue research is
continuing. As mentioned above, researchers have already transplanted dopamine-
producing cells from the fetal brain into patients suffering from Parkinson's disease.
What will happen to the destiny of stem cell research using fetuses, under the present
Bush administration is uncertain.